Saint Louis University Researchers Identify a Biomarker for Severe Liver Disease in Infants

In a new study, Saint Louis University School of Medicine researchers and colleagues have identified biomarkers in high-risk infants with alpha-1 antitrypsin de

Related Keywords

United Kingdom ,United States ,Michigan ,Colorado ,Cambridge ,Cambridgeshire ,University Of Colorado Denver ,America ,Keith Burling ,Keith Steven Blomenkamp ,Paula Buchanan ,Jeffrey Teckman ,Davida Lomas ,Bridjes Oneil ,Nina Heyer Chauhan ,Department Of Health ,Cardinal Glennon Children Hospital Foundation ,Takeda Inc ,Core Biochemical Assay Laboratory ,Data Coordinating Center ,Saint Louis University ,Foundation United States ,Biomedical Research Centre ,Clinical Outcomes Research ,Division Of Medicine ,National Institutes Of Health ,Cambridge University Hospitals ,Saint Louis University Liver Center ,University Of Michigan ,University College London ,Saint Louis University School Of Medicine ,Childhood Liver Disease Research Network Childre ,Research Council United Kingdom ,Health Cardinal Glennon Children Hospital ,Bridjeso Neil ,Saint Louis University School ,Gastro Hep Advances ,Saint Louis ,Childhood Liver Disease Research Network ,National Institutes ,Longitudinal Observational Study ,Genetic Causes ,Intrahepatic Cholestasis ,Molecular Biology ,Cardinal Glennon Children ,University College ,Colorado Denver ,Hospital Colorado ,Medical Research Council ,Newswise ,Aint Louis University School Of Medicine Jeffrey Teckman ,D Liver Disease Pediatrics Alpha 1 Antitrypsin Aat Deficiency Research Life Saving Therapies ,